Search research articles
Contact Us
Filters
Showing results (41-50 of 205) with videos related to
Page
of 21
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 29, 2011
Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease
Ryan L Boudreau, Ryan M Spengler, Beverly L Davidson
Neuron
|
November 17, 2009
MicroRNAs potentiate neural development
Sarah K Fineberg, Kenneth S Kosik, Beverly L Davidson
Current Protocols in Mouse Biology
|
November 6, 2018
Techniques for Intracranial Stereotaxic Injections of Adeno-Associated Viral Vectors in Adult Mice
Megan S Keiser, Yong Hong Chen, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 6, 2018
Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
Yonghong Chen, Shujuan Zheng, Luis Tecedor, et al.
Neuroscience Letters
|
October 30, 2003
Transduction of neurons lining the cerebral external capsules in mice with feline immunodeficiency virus based vectors
Joseph M Alisky, Stephanie M Hughes, Beverly L Davidson
The Journal of Gene Medicine
|
September 11, 2002
Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection
Todd A Derksen, Sybille L Sauter, Beverly L Davidson
Human Molecular Genetics
|
November 16, 2013
Functional microRNAs and target sites are created by lineage-specific transposition
Ryan M Spengler, Clayton K Oakley, Beverly L Davidson
Molecular Therapy. Nucleic Acids
|
May 1, 2013
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure
James C Geoghegan, Brian L Gilmore, Beverly L Davidson
RNA (New York, N.Y.)
|
August 14, 2008
Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs
Ryan L Boudreau, Alex Mas Monteys, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy
Megan S Keiser, Ryan L Boudreau, Beverly L Davidson
Page
of 21
Search research articles
Search
Showing results (41-50 of 205) with videos related to
Sort By:
Page
of 21
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 29, 2011
Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease
Ryan L Boudreau, Ryan M Spengler, Beverly L Davidson
Neuron
|
November 17, 2009
MicroRNAs potentiate neural development
Sarah K Fineberg, Kenneth S Kosik, Beverly L Davidson
Current Protocols in Mouse Biology
|
November 6, 2018
Techniques for Intracranial Stereotaxic Injections of Adeno-Associated Viral Vectors in Adult Mice
Megan S Keiser, Yong Hong Chen, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 6, 2018
Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
Yonghong Chen, Shujuan Zheng, Luis Tecedor, et al.
Neuroscience Letters
|
October 30, 2003
Transduction of neurons lining the cerebral external capsules in mice with feline immunodeficiency virus based vectors
Joseph M Alisky, Stephanie M Hughes, Beverly L Davidson
The Journal of Gene Medicine
|
September 11, 2002
Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection
Todd A Derksen, Sybille L Sauter, Beverly L Davidson
Human Molecular Genetics
|
November 16, 2013
Functional microRNAs and target sites are created by lineage-specific transposition
Ryan M Spengler, Clayton K Oakley, Beverly L Davidson
Molecular Therapy. Nucleic Acids
|
May 1, 2013
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure
James C Geoghegan, Brian L Gilmore, Beverly L Davidson
RNA (New York, N.Y.)
|
August 14, 2008
Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs
Ryan L Boudreau, Alex Mas Monteys, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy
Megan S Keiser, Ryan L Boudreau, Beverly L Davidson
Page
of 21